title: Adalimumab for perianal fistulizing Crohn's disease: real-world data adds important information for clinical practice.
authors.affiliation: *Colorectal Surgery Unit, Cajuru University Hospital, Catholic University of Paraná (PUCPR), Curitiba, Paraná, Brazil †IBD Section, Colorectal Surgery Unit Department of Surgery, Istituto Clinico Humanitas, Milano, Italy.
authors.forename: Paulo G
authors.initials: PG
authors.lastname: Kotze
authors.forename: Antonino
authors.initials: A
authors.lastname: Spinelli
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D003424:Crohn Disease / Q000188:drug therapy*; D017577:Cutaneous Fistula / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D012003:Rectal Fistula / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha